Skip to Content

Jushi Holdings Inc JUSHF

Morningstar Rating
$0.56 0.00 (0.20%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

JUSHF is trading at a 321% premium.
Price
$0.56
Fair Value
$9.99
Uncertainty
Extreme
1-Star Price
$4.33
5-Star Price
$1.76
Economic Moat
Qjrtr
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if JUSHF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.56
Day Range
$0.540.58
52-Week Range
$0.351.09
Bid/Ask
$0.54 / $0.59
Market Cap
$109.90 Mil
Volume/Avg
39,483 / 300,532

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.41
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Jushi Holdings Inc is a vertically integrated multi-state cannabis and hemp operator engaged in retail, distribution, cultivation, and processing in both medical and adult-use markets. The company operates a diverse portfolio of branded cannabis and hemp-derived assets, built upon opportunistic acquisitions, distressed deals, and competitive applications. Operating under the Jushi umbrella is the BEYOND / HELLO retail brand of cannabis dispensaries, hemp-based CBD brand, Nira, including its brands, The Lab: Concentrates and The Bank: Flower + Genetics, as well as its precision-formulated line of medical cannabis products Nira Plus. Jushi strives to maximize shareholder value while delivering high-premium products across all levels of the cannabis and hemp ecosystem.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
1,188

Comparables

Valuation

Metric
JUSHF
CURA
CL
Price/Earnings (Normalized)
52.54
Price/Book Value
2.981.13
Price/Sales
0.412.210.73
Price/Cash Flow
5.5246.086.02
Price/Earnings
JUSHF
CURA
CL

Financial Strength

Metric
JUSHF
CURA
CL
Quick Ratio
0.240.290.83
Current Ratio
0.510.721.36
Interest Coverage
−0.04−0.31−0.95
Quick Ratio
JUSHF
CURA
CL

Profitability

Metric
JUSHF
CURA
CL
Return on Assets (Normalized)
−10.50%−5.56%−4.46%
Return on Equity (Normalized)
−545.34%−16.04%−11.60%
Return on Invested Capital (Normalized)
−9.55%−5.52%−2.45%
Return on Assets
JUSHF
CURA
CL
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
BkhlfmwvPwtn$82.1 Bil
Merck KGaA ADR
MKKGY
HydkfwtgxVqdssdw$75.2 Bil
Haleon PLC ADR
HLN
JnrrbfkpGfm$41.4 Bil
Viatris Inc
VTRS
KlflytngSdxkv$14.4 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
PmykslvpDrt$13.7 Bil
Catalent Inc
CTLT
JypbqrsmRzqpdx$10.6 Bil
Perrigo Co PLC
PRGO
LrtfqhqvhYcsp$3.8 Bil
Prestige Consumer Healthcare Inc
PBH
NkzfxbkrCyszlwz$3.5 Bil
Curaleaf Holdings Inc
CURLF
MrplvztkJhbm$3.0 Bil
Green Thumb Industries Inc
GTBIF
DqpctpksXmv$2.7 Bil

Sponsor Center